Hum. Reprod. Advance Access published online on April 22, 2004
Human Reproduction, doi:10.1093/humrep/deh290
© 2004 by European Society of Human Reproduction and Embryology
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Centre de Recherche, Hôpital Saint-François d’Assise, Centre Hospitalier Universitaire de Québec, Canada; Département d’Obstétrique et Gynécologie, Faculté de Médecine, Université Laval, Québec, Canada
* To whom correspondence should be addressed. E-mail: ali.akoum{at}crsfa.ulaval.ca.
BACKGROUND: For the implantation of endometrium in ectopic locations, remodelling of the extracellular matrix (ECM) is necessary. Many studies have shown an increased expression of various proteases in the ectopic endometrium of women with endometriosis. Few, however, have addressed possible changes in protease expression in the eutopic endometrium. METHODS AND RESULTS: Herein, we reveal an increased release of proteolytic activity by the eutopic endometrium of women with endometriosis compared with normal women (P < 0.01). Using zymography and western blotting, we identified matrix metalloproteinase (MMP)-2 and MMP-9 in the culture medium, and further found that MMP-9 secretion, as assessed by zymography and enzyme-linked immunosorbent assay (ELISA), was elevated in women with endometriosis compared with normal women (P < 0.05). No statistically significant difference in MMP-2 secretion between women with and without endometriosis was noted. However, a significant difference in the levels of the tissue inhibitor of metalloproteinases (TIMP)-1, a known MMP-9 inhibitor, was found (P < 0.05). CONCLUSION: The endometriosis-associated increase in proteolysis and imbalance between the secretion of MMP-9 and that of its natural inhibitor, TIMP-1, revealed in the culture medium of endometrial tissue may reflect in vivo the enhanced capacity of this tissue to break down the ECM in host tissues, thereby favouring its ectopic implantation and development. Key words:
Key words: endometriosis/MMP-9/proteolysis/TIMP-1
Accepted April 2, 2004
Article
Evidence for an increased release of proteolytic activity by the eutopic endometrial tissue in women with endometriosis and for involvement of matrix metalloproteinase-9
2 Département d’Obstétrique et Gynécologie, Faculté de Médecine, Université Laval, Québec, Canada
3 Centre de Recherche, Hôpital Saint-François d’Assise, Centre Hospitalier Universitaire de Québec, Canada; Département d’Obstétrique et Gynécologie, Faculté de Médecine, Université Laval, Québec, Canada; Unité d’Endocrinologie de la Reproduction, Centre de Recherche, Hôpital Saint-François d’Assise, Centre Hospitalier Universitaire de Québec, 10 rue de l’Espinay, Local D0-711, Québec, Québec, Canada, G1L 3L5
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M Pino, C Galleguillos, M Torres, H Sovino, A Fuentes, M A Boric, and M C Johnson Association between MMP1 and MMP9 activities and ICAM1 cleavage induced by tumor necrosis factor in stromal cell cultures from eutopic endometria of women with endometriosis Reproduction, November 1, 2009; 138(5): 837 - 847. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Pitsos and N. Kanakas The Role of Matrix Metalloproteinases in the Pathogenesis of Endometriosis Reproductive Sciences, August 1, 2009; 16(8): 717 - 726. [Abstract] [PDF]
|
|
|
|
 |
|
 P. Akkaya, G. Onalan, N. Haberal, N. Bayraktar, B. Mulayim, and H. B. Zeyneloglu Doxycycline causes regression of endometriotic implants: a rat model Hum. Reprod., August 1, 2009; 24(8): 1900 - 1908. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. D'Amora, T. T. Maciel, R. Tambellini, M. A. Mori, J. B. Pesquero, H. Sato, M. J. B. C. Girao, I. D. C. Guerreiro da Silva, and E. Schor Disrupted Cell Cycle Control in Cultured Endometrial Cells from Patients with Endometriosis Harboring the Progesterone Receptor Polymorphism PROGINS Am. J. Pathol., July 1, 2009; 175(1): 215 - 224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Guay and A Akoum Stable inhibition of interleukin 1 receptor type II in Ishikawa cells augments secretion of matrix metalloproteinases: possible role in endometriosis pathophysiology Reproduction, September 1, 2007; 134(3): 525 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Wren, Y. Wu, and S.-W. Guo A system-wide analysis of differentially expressed genes in ectopic and eutopic endometrium Hum. Reprod., August 1, 2007; 22(8): 2093 - 2102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Collette, R. Maheux, J. Mailloux, and A. Akoum Increased expression of matrix metalloproteinase-9 in the eutopic endometrial tissue of women with endometriosis Hum. Reprod., December 1, 2006; 21(12): 3059 - 3067. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ulukus, H. Cakmak, and A. Arici The Role of Endometrium in Endometriosis Reproductive Sciences, October 1, 2006; 13(7): 467 - 476. [Abstract] [PDF]
|
|
|
|
|
|
M.-H. Wu, Y. Shoji, M.-C. Wu, P.-C. Chuang, C.-C. Lin, M.-F. Huang, and S.-J. Tsai Suppression of Matrix Metalloproteinase-9 by Prostaglandin E2 in Peritoneal Macrophage Is Associated with Severity of Endometriosis Am. J. Pathol., October 1, 2005; 167(4): 1061 - 1069. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Bellehumeur, T. Collette, R. Maheux, J. Mailloux, M. Villeneuve, and A. Akoum Increased soluble interleukin-1 receptor type II proteolysis in the endometrium of women with endometriosis Hum. Reprod., May 1, 2005; 20(5): 1177 - 1184. [Abstract] [Full Text] [PDF]
|
|